標(biāo)題: Titlebook: Cardiac Sarcoidosis; Key Concepts in Path Andrew M. Freeman,Howard D. Weinberger Book 2015 Springer International Publishing Switzerland 20 [打印本頁] 作者: 民俗學(xué) 時間: 2025-3-21 18:32
書目名稱Cardiac Sarcoidosis影響因子(影響力)
書目名稱Cardiac Sarcoidosis影響因子(影響力)學(xué)科排名
書目名稱Cardiac Sarcoidosis網(wǎng)絡(luò)公開度
書目名稱Cardiac Sarcoidosis網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Cardiac Sarcoidosis被引頻次
書目名稱Cardiac Sarcoidosis被引頻次學(xué)科排名
書目名稱Cardiac Sarcoidosis年度引用
書目名稱Cardiac Sarcoidosis年度引用學(xué)科排名
書目名稱Cardiac Sarcoidosis讀者反饋
書目名稱Cardiac Sarcoidosis讀者反饋學(xué)科排名
作者: 流眼淚 時間: 2025-3-21 22:24 作者: Overdose 時間: 2025-3-22 02:30
https://doi.org/10.1007/978-3-658-41443-6ft ventricular free wall, basal ventricular septum, right ventricle, papillary muscles, right atrium, and left atrium. Cardiac involvement occurs in 20–27 % of sarcoidosis patients in the United States and may be as high as 58 % in Japan.作者: epinephrine 時間: 2025-3-22 04:54
https://doi.org/10.1007/978-3-658-38204-9sed in the acute setting, owing to its relatively rapid effect. Although minimal controlled data are available to guide the use of corticosteroids, they have been most effective in resolving AV block. Accordingly, conventional management of VT and HF should be also be utilized.作者: 單純 時間: 2025-3-22 11:07 作者: 煞費(fèi)苦心 時間: 2025-3-22 13:07
https://doi.org/10.1007/978-3-658-38204-9s those without initial indications of cardiac involvement or need for ICD may develop such in the future. This chapter will focus on the role of the ICD in CS in addition to risk stratification in those at risk for SCD with CS.作者: 煞費(fèi)苦心 時間: 2025-3-22 20:33
neue betriebswirtschaftliche forschung (nbf)rformed for this entity with prompt recognition and treatment to prevent the more serious manifestations. Although there is a growing body of evidence to suggest possible benefit of PAH-specific therapies in SAPH, there are no currently FDA approved medications for SAPH.作者: instill 時間: 2025-3-22 21:52 作者: 向外才掩飾 時間: 2025-3-23 01:46
Sarcoidosis-Associated Pulmonary Hypertension,rformed for this entity with prompt recognition and treatment to prevent the more serious manifestations. Although there is a growing body of evidence to suggest possible benefit of PAH-specific therapies in SAPH, there are no currently FDA approved medications for SAPH.作者: 惰性氣體 時間: 2025-3-23 08:20 作者: 姑姑在炫耀 時間: 2025-3-23 13:41
,Hinweise für die Erstellung der Analyse,r high degree heart block, severe valvular disease or cardiomyopathy and heart failure. There is no standard or routine test for cardiac sarcoidosis and its diagnosis depends on an expert team, a careful history and physical, and appropriate testing.作者: sperse 時間: 2025-3-23 15:11
Die untersch?tzte Macht technischer Normenand the development of both a wide variety of atrial and ventricular arrhythmias. There are several treatment strategies, and in appropriate patients, pharmacologic along with device therapy may be indicated.作者: 流浪者 時間: 2025-3-23 20:15 作者: murmur 時間: 2025-3-23 22:54
Clinical Presentations,r high degree heart block, severe valvular disease or cardiomyopathy and heart failure. There is no standard or routine test for cardiac sarcoidosis and its diagnosis depends on an expert team, a careful history and physical, and appropriate testing.作者: Optic-Disk 時間: 2025-3-24 06:20
Management of Arrhythmias Related to Cardiac Sarcoidosis,and the development of both a wide variety of atrial and ventricular arrhythmias. There are several treatment strategies, and in appropriate patients, pharmacologic along with device therapy may be indicated.作者: 中和 時間: 2025-3-24 08:48 作者: Sigmoidoscopy 時間: 2025-3-24 13:02 作者: 清楚說話 時間: 2025-3-24 14:51
Pathophysiology: From Genetics to Viruses and More,ft ventricular free wall, basal ventricular septum, right ventricle, papillary muscles, right atrium, and left atrium. Cardiac involvement occurs in 20–27 % of sarcoidosis patients in the United States and may be as high as 58 % in Japan.作者: 漂亮 時間: 2025-3-24 20:50 作者: capillaries 時間: 2025-3-25 03:06
Rechtliche Motive zur Verwendung von Normen,ng are all helpful in the diagnosis and surveillance of cardiac sarcoidosis. Ambulatory monitoring has emerged as one of the more powerful tools to detect cardiac involvement, though an emerging composite scoring system may help even further.作者: 粗野 時間: 2025-3-25 06:16
https://doi.org/10.1007/978-3-658-38204-9 studies can augment the likelihood of gathering affected tissue, but biopsy sensitivity still remains relatively low. As such, invasive study is certainly useful, but routine use is likely less in line with current standard practice.作者: BIPED 時間: 2025-3-25 09:34
Standard Screening for Cardiac Sarcoidosis,ng are all helpful in the diagnosis and surveillance of cardiac sarcoidosis. Ambulatory monitoring has emerged as one of the more powerful tools to detect cardiac involvement, though an emerging composite scoring system may help even further.作者: 比賽用背帶 時間: 2025-3-25 13:09
Invasive Procedures and Endomyocardial Biopsy, studies can augment the likelihood of gathering affected tissue, but biopsy sensitivity still remains relatively low. As such, invasive study is certainly useful, but routine use is likely less in line with current standard practice.作者: SNEER 時間: 2025-3-25 15:56 作者: epinephrine 時間: 2025-3-26 00:01 作者: Budget 時間: 2025-3-26 00:57
Multimodality Imaging of Cardiac Sarcoidosis,rmalities that are concerning for cardiac sarcoidosis. However, once disease is identified, PET should be used to determine the response to therapy as well as the burden of active extra-cardiac disease. Notably, cardiac MRI and PET are more sensitive than echocardiography and clinical criteria, and 作者: –scent 時間: 2025-3-26 05:25
Immunosuppressive Management of Cardiac Sarcoidosis,ssue, and reduce or prevent the development of serious or life threatening cardiac complications. Management of cardiac sarcoidosis requires the collaborative effort of a sarcoidosis expert, an electrophysiologist, and a general cardiologist.作者: amphibian 時間: 2025-3-26 08:52 作者: 使顯得不重要 時間: 2025-3-26 16:30
https://doi.org/10.1007/978-3-662-28360-8exams may be useful for determining the response to therapy. The development of future tracers will further increase the capabilities of nuclear imaging techniques to guide the diagnosis and treatment of patients with cardiac sarcoidosis.作者: OUTRE 時間: 2025-3-26 18:03
https://doi.org/10.1007/978-3-658-38204-9rmalities that are concerning for cardiac sarcoidosis. However, once disease is identified, PET should be used to determine the response to therapy as well as the burden of active extra-cardiac disease. Notably, cardiac MRI and PET are more sensitive than echocardiography and clinical criteria, and 作者: Jejune 時間: 2025-3-27 01:01
https://doi.org/10.1007/978-3-658-38204-9ssue, and reduce or prevent the development of serious or life threatening cardiac complications. Management of cardiac sarcoidosis requires the collaborative effort of a sarcoidosis expert, an electrophysiologist, and a general cardiologist.作者: 繁忙 時間: 2025-3-27 05:11
https://doi.org/10.1007/978-3-319-14624-9Cardiac Sarcoidosis; Epidemiology; Pathophysiology; Sarcoidosis Team Approach; Sarcoidosis-related Pulmo作者: Atmosphere 時間: 2025-3-27 06:34 作者: COW 時間: 2025-3-27 09:27
Externe Effekte und kollektives Handeln will walk the reader through difficult cases in the management of real-life cases of sarcoidosis with cardiac involvement. Imaging results, catheterization and biopsy results, clinical scenarios, and pitfalls in the care of these patients will be reviewed through case examples with summaries of key points.作者: saphenous-vein 時間: 2025-3-27 13:47
Andrew M. Freeman,Howard D. WeinbergerContains high-yield practical information in understanding the cardiac disease processes.Increases understanding of the disease from risk factors for its development through diagnosis using the latest作者: allergen 時間: 2025-3-27 18:17 作者: 紀(jì)念 時間: 2025-3-28 00:26 作者: CROAK 時間: 2025-3-28 02:06 作者: Morose 時間: 2025-3-28 09:05 作者: Condyle 時間: 2025-3-28 11:28
Rechtliche Motive zur Verwendung von Normen,ons of cardiac sarcoidosis. A high clinical index of suspicion and regular surveillance in appropriate individuals is an important clinical management philosophy. Unfortunately, the severity of pulmonary disease does not predict cardiac involvement, and cardiac involvement can often present after pu作者: ALT 時間: 2025-3-28 16:52
Rechtliche Motive zur Verwendung von Normen,ional abnormalities and associated features of cardiac sarcoidosis. Cardiac magnetic resonance imaging (MRI) employs delayed hyperenhancement (DHE) sequences for the detection of bright (high signal intensity) scar in the myocardium as well as T2 imaging for inflammation and cinematic movie imaging 作者: rectum 時間: 2025-3-28 19:57 作者: Cervical-Spine 時間: 2025-3-29 00:27 作者: galley 時間: 2025-3-29 04:21
https://doi.org/10.1007/978-3-658-38204-9he development of coronary disease. More common is the need for tissue diagnosis for the confirmation of a clinical scenario which suggests myocardial involvement by sarcoidosis granulomatous infiltration. While endomyocardial biopsy is the “gold standard” for a diagnosis of myocardial sarcoidosis, 作者: 逢迎白雪 時間: 2025-3-29 08:39
Die untersch?tzte Macht technischer Normenves serious attention and a careful, comprehensive workup. Conduction disease can range from blocks at virtually all levels of the conduction system, and the development of both a wide variety of atrial and ventricular arrhythmias. There are several treatment strategies, and in appropriate patients,作者: Obstruction 時間: 2025-3-29 12:56 作者: 凝結(jié)劑 時間: 2025-3-29 19:09 作者: BUOY 時間: 2025-3-29 21:55
https://doi.org/10.1007/978-3-658-38204-9% of deaths in sarcoidosis and may be its first manifestation. Once cardiac involvement is suspected or identified, efforts should be made to further stratify a patient’s risk of sudden cardiac death by some combination of ECG, electrophysiologic testing, echocardiogram, and advanced imaging. In add作者: LURE 時間: 2025-3-30 00:07 作者: mosque 時間: 2025-3-30 05:30
Externe Effekte und kollektives Handeln will walk the reader through difficult cases in the management of real-life cases of sarcoidosis with cardiac involvement. Imaging results, catheterization and biopsy results, clinical scenarios, and pitfalls in the care of these patients will be reviewed through case examples with summaries of key作者: 運(yùn)氣 時間: 2025-3-30 09:33 作者: 顯示 時間: 2025-3-30 15:13 作者: Neuralgia 時間: 2025-3-30 17:31 作者: 察覺 時間: 2025-3-30 20:52
High Yield Epidemiology,s in incidence, racial and ethnic factors, and clinical presentation variations will be described in detail. Sarcoidosis most often presents in African American persons, particularly in cases described in North America, and is usually a disease of early middle age. In some parts of the world, such a
